1h Free Analyst Time
The injection pen market is forecasted to grow by USD 28.61 billion during 2024-2029, accelerating at a CAGR of 8.4% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growing prevalence of diabetes cases, and growing popularity of injectable therapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The injection pen market is segmented as below:
By Product
- Growth hormone
- Diabetes
- Fertility
- Osteoporosis
- Others
By Type
- Disposable injection pen
- Reusable injection pen
By End-user
- Hospitals
- Homecare settings
- ASCs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the injection pen market covers the following areas:
- Injection Pen Market sizing
- Injection Pen Market forecast
- Injection Pen Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Type
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global injection pen market: AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi SA, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is significant rise in demand for insulin pens."
According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Becton Dickinson and Co.
- Biocon Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gan and Lee Pharmaceuticals Co. Ltd.
- Gerresheimer AG
- GlaxoSmithKline Plc
- Harro Hofliger GmbH
- Haselmeier GmbH
- Jiangsu Delfu medical device Co. Ltd.
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Owen Mumford Ltd.
- Pfizer Inc.
- Sanofi SA
- Solteam Electronics Co LTD.
- Viatris Inc.
- Ypsomed Holding AG
